Icon plc Stock
Icon plc gained 0.120% compared to yesterday.
Icon plc is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
As a result the target price of 191 € shows a very positive potential of 91.77% compared to the current price of 99.6 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.120% | 0.954% | 13.355% | -24.090% | -35.799% | -43.138% | - |
| Alkermes plc | -0.730% | 1.547% | 14.643% | 14.643% | 22.415% | 13.740% | 62.303% |
| Ligand Pharmaceuticals | 2.070% | -2.030% | 16.265% | 102.094% | 16.265% | 175.714% | 60.499% |
| United Therapeutics | 1.150% | -0.634% | 6.975% | 89.478% | 13.784% | 132.632% | 186.000% |
Comments
Icon (ICLR) was upgraded by BMO Capital Markets from "market perform" to "outperform". They now have a $130.00 price target on the stock, up from $100.00.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat